Evolving challenges in hepatic fibrosis

SL Friedman - Nature reviews Gastroenterology & hepatology, 2010 - nature.com
Continued elucidation of the mechanisms of hepatic fibrosis has yielded a comprehensive
and nuanced portrait of fibrosis progression and regression. The paradigm of hepatic …

Fermentation, a feasible strategy for enhancing bioactivity of herbal medicines

A Hussain, S Bose, JH Wang, MK Yadav… - Food Research …, 2016 - Elsevier
Herbal drugs, which possess immunomodulatory, anti-inflammatory, anti-diabetic, anti-
infective, and anti-allergic activities, encompass various therapeutic areas, and have been …

Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis

X Han, N Gong, L Xue, MM Billingsley… - Nature …, 2023 - nature.com
Lipid nanoparticle-mediated RNA delivery holds great potential to treat various liver
diseases. However, targeted delivery of RNA therapeutics to activated liver-resident …

[HTML][HTML] Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1

P Luo, D Liu, Q Zhang, F Yang, YK Wong, F Xia… - … Pharmaceutica Sinica B, 2022 - Elsevier
Ferroptosis is a form of regulated cell death, characterized by excessive membrane lipid
peroxidation in an iron-and ROS-dependent manner. Celastrol, a natural bioactive …

Antifibrotic effects of the dual CCR2/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis

E Lefebvre, G Moyle, R Reshef, LP Richman… - PloS one, 2016 - journals.plos.org
Background & Aims Interactions between CC chemokine receptor types 2 (CCR2) and 5
(CCR5) and their ligands, including CCL2 and CCL5, mediate fibrogenesis by promoting …

Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study

EM Koehler, EPC Plompen, JNL Schouten… - Hepatology, 2016 - journals.lww.com
Given that little is known about the prevalence of, and factors associated with, liver fibrosis in
the general population, we aimed to investigate this in a large, well‐characterized cohort by …

[PDF][PDF] Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys …

Y Lee, SU Kim, K Song, JY Park, DY Kim, SH Ahn… - …, 2016 - Wiley Online Library
Sarcopenia is associated with nonalcoholic fatty liver disease (NAFLD). This study
investigated whether sarcopenia is associated with significant liver fibrosis in subjects with …

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

D Kim, RW Kim, HJ Kim, TM Therneau - Hepatology, 2013 - journals.lww.com
The clinical and public health significance of nonalcoholic fatty liver disease (NAFLD) is not
well established. We investigated the long-term effect of NAFLD on mortality. This analysis …

Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2

AJ O'brien, JN Fullerton, KA Massey, G Auld… - Nature medicine, 2014 - nature.com
Liver disease is one of the leading causes of death worldwide. Patients with cirrhosis display
an increased predisposition to and mortality from infection due to multimodal defects in the …

LECT2, a ligand for Tie1, plays a crucial role in liver fibrogenesis

M Xu, HH Xu, Y Lin, X Sun, LJ Wang, ZP Fang, XH Su… - Cell, 2019 - cell.com
Liver fibrosis is a very common condition seen in millions of patients with various liver
diseases, and yet no effective treatments are available owing to poorly characterized …